SkinBioTherapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. SkinBioTherapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1517% to $1,208,669. Profit margin reached -238%. Total operating expenses were $3,588,170.
Profit Margin
| 2016 | 2.76K | -4.20K | -151.72% |
|---|---|---|---|
| 2018 | 0 | -844.41K | |
| 2019 | 0 | -1.14M | |
| 2021 | 0 | -1.43M | |
| 2022 | 74.76K | -2.79M | -3735.37% |
| 2024 | 1.20M | -2.87M | -237.95% |
SBTX.L Income Statement (2015 – 2023)
| 2023 | 2021 | 2020 | 2018 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 1.20M | 74.76K | 0 | 0 | 0 | 2.76K |
Cost of revenue | 525.63K | 58.84K | 5.05K | 3.4K | 0 | 0 |
Gross profit | 683.03K | 15.91K | -5.05K | -3.4K | 0 | 2.76K |
Operating exp. | ||||||
Research and development | 562.91K | 861.38K | 505.62K | 708.08K | 415.90K | 1.29K |
Selling and marketing | 170.59K | 43.80K | 0 | 0 | 0 | 0 |
Total operating expenses | 3.58M | 2.99M | 1.48M | 1.35M | 941.19K | 4.20K |
Operating income | -2.90M | -2.98M | -1.49M | -1.35M | -941.19K | -4.2K |
Other income (expenses), net | -43.76K | -11.26K | -926 | -1.70K | 0 | 0 |
Income before tax | -2.94M | -2.99M | -1.49M | -1.36M | -941.45K | -4.20K |
Income tax expense | -72.90K | -199.62K | -65.06K | -212.38K | -97.03K | 0 |
Net income | -2.87M | -2.79M | -1.43M | -1.14M | -844.41K | -4.20K |
Earnings per share | ||||||
Basic EPS | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | 0 |
Diluted EPS | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | 0 |
| Data source | Data source | Data source | Data source | Data source | Data source |